How A Small Tweak In The Patent System 25 Years Ago Hurts You Today

from the doesn't-look-good dept

Usually when we're talking about issues with the patent system, we're focused on how it applies to technology -- often software. However, one area where people always like to insist we're completely wrong about patents often causing more problems than they solve is in the pharmaceutical field. With the cost of pharmaceutical research so high, the claim is, no new drugs would ever get made without strong patent protection. Of course, it turns out that patents are being abused badly in the pharmaceutical/medical field as well -- often in much the same way as technology patents. Slashdot points to this fascinating article in Fortune that shows how federally funded, University owned patents have been used to stifle innovation repeatedly, driving up costs significantly. And, the unintended consequences go much further. Because of the lucrative nature of these kinds of patents, researchers no longer share information with each other. As the article makes clear, plenty of medical research breakthroughs came about as people built on the ideas of others. However, now, many researchers (and the universities that employ them) are staying as quiet as possible until patents are filed -- thus slowing down the collaboration needed for real innovation. In fact, the article looks at the biotech field that was supposedly created by the change in patent law that made it easier for universities to license their patents and found plenty of evidence that rather than create a booming industry, the system has actually harmed real innovation, slowed drug discovery for certain diseases and (of course) driven up prices for everyone.
Hide this

Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.

Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.

While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.

–The Techdirt Team

Reader Comments

Subscribe: RSS

View by: Time | Thread

  1. identicon
    Tim, 15 Sep 2005 @ 3:38am

    No Subject Given

    It's been nearly 3 weeks, but I don't see people talking about the role of pharmaceutical patents in the inclusion of bulk drugs in India's aid offering:

    It does't take much effort to wonder if some of these drugs were patented in the US leading to production and distribution problems.

    Actually, does anyone know if the US actually *accepted* this offer, anyway?

Add Your Comment

Have a Techdirt Account? Sign in now. Want one? Register here

Subscribe to the Techdirt Daily newsletter

Comment Options:

  • Use markdown. Use plain text.
  • Make this the First Word or Last Word. No thanks. (get credits or sign in to see balance)    
  • Remember name/email/url (set a cookie)

Follow Techdirt
Special Affiliate Offer

Essential Reading
Techdirt Deals
Report this ad  |  Hide Techdirt ads
Techdirt Insider Chat
Recent Stories

This site, like most other sites on the web, uses cookies. For more information, see our privacy policy. Got it

Email This

This feature is only available to registered users. Register or sign in to use it.